about
Pathological outcomes and strategies to achieve optimal cancer control during robotic radical prostatectomy in Asian-Indian menIs robotic technology facilitating the minimally invasive approach to partial nephrectomy?Optimizing radical prostatectomy for the early recovery of urinary continence.Vancomycin resistant enterococci in urine cultures: Antibiotic susceptibility trends over a decade at a tertiary hospital in the United Kingdom.Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profilesLESSons in minimally invasive urology.Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies.Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.The importance of surgical margins in prostate cancer.Detailed analysis of operating time learning curves in robotic prostatectomy by a novice surgeon.Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.Surgical margin length and location affect recurrence rates after robotic prostatectomy.Direct visualization of the trimeric structure of the ASIC1a channel, using AFM imaging.Single-Site Surgery: More oR-LESS?Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cellsLetter to the editor of IJS
P50
Q24635051-2CC7526C-F314-410F-9A34-B1F6FD736C35Q34027832-BF4D7335-DE22-448C-B222-322819E58CC4Q34249132-D46094AC-B4D6-48A6-8FB3-9352A82D16BCQ36686664-FB8320E8-BC5D-420A-BBAC-D2D6B0412EC0Q36954794-0101BB5D-D65B-426B-8FEB-4862793F35DBQ37800967-FC1D952B-D7CF-4222-99FC-2AC19EB91E7DQ38261640-589FA853-BDAC-42F6-A479-1856519E83AAQ38603110-2183B8BF-9FFD-4A84-836A-F575B84EA065Q38785318-E6F4EF07-5181-4E8D-BB12-D20C937DE5BDQ39692602-C38B8D79-1FF9-4E99-9E55-176D164C9E49Q40933499-73702CCA-BC53-4408-9FCE-9DE18E05F76BQ41685233-E470397C-AD1D-4456-82C9-64549EDF4C8EQ48539777-5A2AE89E-E178-4A69-B0F5-6CDCEF382584Q51658453-CEF50D33-F9FE-4963-BD13-8AF42D667889Q59313925-E695C4AB-3DDB-4926-B490-413357E79CE1Q84521728-BC0FD157-F4EF-4BAB-B359-E9A411DC3F6D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Harveer Dev
@ast
Harveer Dev
@en
Harveer Dev
@es
Harveer Dev
@nl
type
label
Harveer Dev
@ast
Harveer Dev
@en
Harveer Dev
@es
Harveer Dev
@nl
prefLabel
Harveer Dev
@ast
Harveer Dev
@en
Harveer Dev
@es
Harveer Dev
@nl
P106
P31
P496
0000-0003-2874-6894